Meet the AION TempShield™

“The TempShield is to cancer patients like the glucose monitor is to diabetics. We have seen that the Tempshield is the difference between an antibiotic and a hospitalization.”

Dr. Tallat Mahmood
Medical Director at Roswell Park Cancer, Ellis Medicine

Meet the AION TempShield™

“The TempShield is to cancer patients like the glucose monitor is to diabetics. We have seen that the Tempshield is the difference between an antibiotic and a hospitalization.”

Dr. Tallat Mahmood
Medical Director at Roswell Park Cancer, Ellis Medicine

Advancing Early Infection Detection

AION TempShield™ is improving outcomes by detecting infections early. Hear from patients and the Director of Medical Oncology at Roswell Park Cancer Center, Ellis Medicine.

Features of the AION TempShield™

  • FDA Clearance

    FDA-cleared Class II medical device.

  • Continuous Body Temperature Monitoring

    24/7 Real-Time Tracking.

  • Long Battery Life

    Up to 90 days of usage per charge.

  • Cost-Effective & Reimbursable

    Low cost, reimbursable under CMS code 99454.

  • Advanced Connectivity

    Bluetooth compatibility, mobile app integration, and seamless EMR (Electronic Medical Record) integration.

  • Clinician Tools

    Dedicated dashboard for healthcare providers.

  • Comfortable Design

    Unparalleled comfort with a low-profile form factor.

Interested in learning about an AION Biosystems™ demo program?

INQUIRE HERE

Earlier Detection of Infection is Critical

  • Allows for timely initiation of appropriate treatment
  • Reduces the risk of complications, hospitalizations, or long-term health consequences associated with untreated or inadequetly treated infections
  • Can result in cost savings for both patients and healthcare systems

Who can benefit?

Cancer
Post Operation
Sepsis
Pediatrics
Long-Term Care

News

  • 2025/03/06

    First of its kind study conducted on Schenectady cancer patients

    READ MORE

  • 2025/02/28

    New technology to monitor cancer patients, detect infection early

    READ MORE